Cargando…

Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease

Alzheimer’s disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal ento...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Kun, Li, Emmy, Eser, Rana, Piergies, Antonia, Sit, Rene, Tan, Michelle, Neff, Norma, Li, Song Hua, Rodriguez, Roberta Diehl, Suemoto, Claudia Kimie, Leite, Renata Elaine Paraizo, Ehrenberg, Alexander J., Pasqualucci, Carlos A., Seeley, William W., Spina, Salvatore, Heinsen, Helmut, Grinberg, Lea T., Kampmann, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854528/
https://www.ncbi.nlm.nih.gov/pubmed/33432193
http://dx.doi.org/10.1038/s41593-020-00764-7
_version_ 1783646097292394496
author Leng, Kun
Li, Emmy
Eser, Rana
Piergies, Antonia
Sit, Rene
Tan, Michelle
Neff, Norma
Li, Song Hua
Rodriguez, Roberta Diehl
Suemoto, Claudia Kimie
Leite, Renata Elaine Paraizo
Ehrenberg, Alexander J.
Pasqualucci, Carlos A.
Seeley, William W.
Spina, Salvatore
Heinsen, Helmut
Grinberg, Lea T.
Kampmann, Martin
author_facet Leng, Kun
Li, Emmy
Eser, Rana
Piergies, Antonia
Sit, Rene
Tan, Michelle
Neff, Norma
Li, Song Hua
Rodriguez, Roberta Diehl
Suemoto, Claudia Kimie
Leite, Renata Elaine Paraizo
Ehrenberg, Alexander J.
Pasqualucci, Carlos A.
Seeley, William W.
Spina, Salvatore
Heinsen, Helmut
Grinberg, Lea T.
Kampmann, Martin
author_sort Leng, Kun
collection PubMed
description Alzheimer’s disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal entorhinal cortex and the superior frontal gyrus – brain regions where neurofibrillary inclusions and neuronal loss occur early and late in AD, respectively – from postmortem brains spanning the progression of AD-type tau neurofibrillary pathology. We identified RORB as a marker of selectively vulnerable excitatory neurons in the entorhinal cortex, and subsequently validated their depletion and selective susceptibility to neurofibrillary inclusions during disease progression using quantitative neuropathological methods. We also discovered an astrocyte subpopulation, likely representing reactive astrocytes, characterized by decreased expression of genes involved in homeostatic functions. Our characterization of selectively vulnerable neurons in AD paves the way for future mechanistic studies of selective vulnerability and potential therapeutic strategies for enhancing neuronal resilience.
format Online
Article
Text
id pubmed-7854528
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-78545282021-07-11 Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease Leng, Kun Li, Emmy Eser, Rana Piergies, Antonia Sit, Rene Tan, Michelle Neff, Norma Li, Song Hua Rodriguez, Roberta Diehl Suemoto, Claudia Kimie Leite, Renata Elaine Paraizo Ehrenberg, Alexander J. Pasqualucci, Carlos A. Seeley, William W. Spina, Salvatore Heinsen, Helmut Grinberg, Lea T. Kampmann, Martin Nat Neurosci Article Alzheimer’s disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal entorhinal cortex and the superior frontal gyrus – brain regions where neurofibrillary inclusions and neuronal loss occur early and late in AD, respectively – from postmortem brains spanning the progression of AD-type tau neurofibrillary pathology. We identified RORB as a marker of selectively vulnerable excitatory neurons in the entorhinal cortex, and subsequently validated their depletion and selective susceptibility to neurofibrillary inclusions during disease progression using quantitative neuropathological methods. We also discovered an astrocyte subpopulation, likely representing reactive astrocytes, characterized by decreased expression of genes involved in homeostatic functions. Our characterization of selectively vulnerable neurons in AD paves the way for future mechanistic studies of selective vulnerability and potential therapeutic strategies for enhancing neuronal resilience. 2021-01-11 2021-02 /pmc/articles/PMC7854528/ /pubmed/33432193 http://dx.doi.org/10.1038/s41593-020-00764-7 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Leng, Kun
Li, Emmy
Eser, Rana
Piergies, Antonia
Sit, Rene
Tan, Michelle
Neff, Norma
Li, Song Hua
Rodriguez, Roberta Diehl
Suemoto, Claudia Kimie
Leite, Renata Elaine Paraizo
Ehrenberg, Alexander J.
Pasqualucci, Carlos A.
Seeley, William W.
Spina, Salvatore
Heinsen, Helmut
Grinberg, Lea T.
Kampmann, Martin
Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title_full Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title_fullStr Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title_full_unstemmed Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title_short Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
title_sort molecular characterization of selectively vulnerable neurons in alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854528/
https://www.ncbi.nlm.nih.gov/pubmed/33432193
http://dx.doi.org/10.1038/s41593-020-00764-7
work_keys_str_mv AT lengkun molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT liemmy molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT eserrana molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT piergiesantonia molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT sitrene molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT tanmichelle molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT neffnorma molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT lisonghua molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT rodriguezrobertadiehl molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT suemotoclaudiakimie molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT leiterenataelaineparaizo molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT ehrenbergalexanderj molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT pasqualuccicarlosa molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT seeleywilliamw molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT spinasalvatore molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT heinsenhelmut molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT grinbergleat molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease
AT kampmannmartin molecularcharacterizationofselectivelyvulnerableneuronsinalzheimersdisease